Global Lung Cancer Diagnostic Test Market is estimated to be US$ 4.07 billion by 2030 with a CAGR of 7.50% during the forecast period - By PMI
April 19, 2022 09:52 ET | PMI
Covina, April 19, 2022 (GLOBE NEWSWIRE) -- Lung cancer starts in the lungs and can spread to the lymph nodes or other body organs, including the brain. Cancer that has progressed to other organs can...
Global Bioinformatics Platform Market is estimated to be US$ 14.0 Billion by 2029 with a CAGR of 14.7% during the Forecast Period - PMI
June 15, 2020 11:35 ET | PMI
Covina, CA, June 15, 2020 (GLOBE NEWSWIRE) -- The global bioinformatics platform market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to...
Burning Rock deepens cooperation with Illumina to promote development and standardization of NGS-based cancer therapy selection in China
May 10, 2020 20:00 ET | Burning Rock Biotech Limited
SHANGHAI, China, May 10, 2020 (GLOBE NEWSWIRE) -- Burning Rock and Illumina (NASDAQ: ILMN), a global leader in gene sequencing and array-based technologies, jointly announced today that they are...
Shareholders Foundation
Update: Lawsuit for Investors in NASDAQ: ILMN shares against Illumina, Inc. announced by Shareholders Foundation
June 12, 2018 09:10 ET | Shareholders Foundation, Inc.
SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Illumina, Inc. (NASDAQ:ILMN).  Investors, who...
Harvard Pilgrim and Illumina sign first-of-its-kind value-based contract
February 20, 2018 10:00 ET | Real Endpoints
SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one...
ILMN LOSS ALERT: Rosen Law Firm Reminds Illumina, Inc. Investors of Important Deadline in Class Action – ILMN
January 24, 2017 20:35 ET | The Rosen Law Firm PA
NEW YORK, Jan. 24, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Illumina, Inc. securities (NASDAQ:ILMN) from July 26, 2016 through October 10,...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Illumina, Inc. – ILMN
January 06, 2017 12:21 ET | The Rosen Law Firm PA
NEW YORK, Jan. 06, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Illumina, Inc. securities...
Cloudera Becomes Founding Member of Lockheed Martin Healthcare Technology Alliance
August 03, 2015 07:00 ET | Cloudera Inc.
PALO ALTO, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Cloudera, the leader in enterprise analytic data management powered by Apache Hadoop™, today announced it has joined a new healthcare...
GenoLogics Life Sciences Software Inc Logo
Illumina CLIA lab subscribes to Clarity LIMS to augment existing informatics infrastructure
February 25, 2013 07:00 ET | GenoLogics Life Sciences Software Inc
Victoria, BC, Canada, Feb. 25, 2013 (GLOBE NEWSWIRE) -- GenoLogics Life Science Software, a leading provider of laboratory information management systems (LIMS) designed for today's omics labs...
Invivoscribe Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire Clinically-Actionable Genetic Test Menu
December 04, 2012 08:36 ET | Invivoscribe
SAN DIEGO, CA--(Marketwire - Dec 4, 2012) - Invivoscribe Technologies, Inc., a privately-held life science company based in San Diego, California, announces the launch of Genection, Inc. ...